Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that the company will present data from ...
Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.
There is a history of studying relaxin in cardiovascular settings—Novartis started a phase 3 heart failure trial of a recombinant relaxin-2 peptide in 2013—but preclinical evidence of the molecule’s ...
The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.
Biotech Vertex, known for its cystic fibrosis therapies, is set to report earnings on Feb. 12 ...
Prosecutors say the executives were encouraging investors to buy more stocks for the drug knowing that it had been denied ...
Every high-voltage electrical application in today’s world requires monitoring, whether it’s on the electrical grid and making sure that the nominal current is flowing downstream, or in a motor and ...
The global cannabis use disorder market is rapidly expanding, driven by increased recognition of cannabis use as a public health issue and the ongoing development of investigational treatments, ...
When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what is happening inside their own bodies. "I tell them to picture ...
BridgeBio's pipeline assets like encaleret and BBP-418 offer optionality but lack near-term cash flow and face regulatory ...
Explore innovative anxiety and PTSD treatments with Addex Therapeutics' groundbreaking research on mGlu7 modulators.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results